By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BIND Therapeutics 

101 Binney Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-491-3400 Fax: 617-491-0351


Company News
BIND Therapeutics (BIND) Stock Soars After Accepting Pfizer (PFE)’s ‘Stalking Horse’ Asset Bid 7/5/2016 6:27:40 AM
BIND Therapeutics (BIND) Loses Two Polaris-Affiliated Board Directors 6/17/2016 8:16:41 AM
BIND Therapeutics (BIND)'s Bankruptcy Filing Worries Developers Of Nanoparticle Cancer Drugs 5/24/2016 7:32:36 AM
BIND Therapeutics (BIND) Provides Update On Chapter 11 Proceedings And Announces Agreement With Hercules Technology III, L.P. 5/19/2016 11:02:03 AM
BIND Therapeutics (BIND) Release: Data Published In Journal Of Controlled Release Demonstrate Flexibility Of ACCURINS To Encapsulate A Broad Range Of Physically And Chemically Diverse Payloads With High Encapsulation Efficiency And Tunable Release Kinetics 5/10/2016 10:57:44 AM
BIND Therapeutics (BIND) Reports First Quarter 2016 Financial Results And Provides Business Update 5/9/2016 10:52:37 AM
BIND Therapeutics (BIND) Announces Collaboration With Affilogic To Provide BIND With Access To Targeting Ligands That Are Key Modulators Of Anti-Tumor Immunity 5/5/2016 11:10:48 AM
BIND Therapeutics (BIND) To Report First Quarter 2016 Financial Results On May 9, 2016 5/4/2016 11:14:27 AM
Cambridge's BIND Therapeutics (BIND) Files for Chapter 11 and Reviews Strategic Alternatives 5/2/2016 6:01:58 AM
Peptidream Announces Research Collaboration With BIND Therapeutics (BIND) 4/6/2016 10:17:10 AM